Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Alphavirus Infections | 2 | 2019 | 68 | 1.42 | Why? |
| Alphavirus | 2 | 2018 | 90 | 0.84 | Why? |
| Arenaviruses, Old World | 1 | 2019 | 4 | 0.83 | Why? |
| Single-Domain Antibodies | 3 | 2020 | 744 | 0.76 | Why? |
| Camelids, New World | 1 | 2020 | 276 | 0.75 | Why? |
| Cytoplasmic Granules | 1 | 2015 | 53 | 0.57 | Why? |
| DNA-Binding Proteins | 1 | 2015 | 469 | 0.46 | Why? |
| Herpesvirus 1, Human | 1 | 2015 | 286 | 0.46 | Why? |
| Carrier Proteins | 1 | 2015 | 513 | 0.45 | Why? |
| Semliki forest virus | 3 | 2018 | 10 | 0.38 | Why? |
| RNA, Messenger | 1 | 2019 | 5131 | 0.29 | Why? |
| Models, Molecular | 2 | 2020 | 7616 | 0.29 | Why? |
| Benzamides | 2 | 2018 | 421 | 0.28 | Why? |
| Amino Acid Motifs | 2 | 2018 | 620 | 0.28 | Why? |
| Viral Nonstructural Proteins | 2 | 2018 | 4810 | 0.25 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.24 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.24 | Why? |
| Spike Glycoprotein, Coronavirus | 6 | 2021 | 37182 | 0.21 | Why? |
| Viral Structural Proteins | 1 | 2004 | 491 | 0.21 | Why? |
| Eukaryotic Initiation Factor-2 | 1 | 2019 | 81 | 0.20 | Why? |
| Protein Binding | 5 | 2020 | 11430 | 0.19 | Why? |
| RNA Processing, Post-Transcriptional | 1 | 2019 | 110 | 0.19 | Why? |
| Cytoskeletal Proteins | 1 | 2018 | 63 | 0.18 | Why? |
| Codon, Terminator | 1 | 2018 | 72 | 0.18 | Why? |
| Cricetinae | 4 | 2018 | 3344 | 0.17 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 113 | 0.17 | Why? |
| Blood Specimen Collection | 1 | 2021 | 387 | 0.17 | Why? |
| Cell Line | 5 | 2019 | 12040 | 0.16 | Why? |
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 179 | 0.16 | Why? |
| Binding Sites | 2 | 2020 | 6201 | 0.16 | Why? |
| Protein Transport | 1 | 2018 | 487 | 0.16 | Why? |
| Viral Proteins | 1 | 2015 | 7370 | 0.15 | Why? |
| Antibodies, Neutralizing | 7 | 2021 | 25288 | 0.15 | Why? |
| Cryoelectron Microscopy | 2 | 2020 | 2372 | 0.15 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 347 | 0.15 | Why? |
| Poly-ADP-Ribose Binding Proteins | 1 | 2015 | 47 | 0.15 | Why? |
| RNA Recognition Motif Proteins | 1 | 2015 | 49 | 0.15 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.15 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2018 | 385 | 0.15 | Why? |
| Peptidomimetics | 1 | 2017 | 202 | 0.15 | Why? |
| Protein Biosynthesis | 1 | 2019 | 653 | 0.14 | Why? |
| Animals | 11 | 2021 | 78931 | 0.14 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.14 | Why? |
| Vaccines, DNA | 1 | 2021 | 871 | 0.14 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 502 | 0.14 | Why? |
| Proteolysis | 1 | 2018 | 751 | 0.13 | Why? |
| DNA Helicases | 1 | 2015 | 203 | 0.13 | Why? |
| Stress, Physiological | 1 | 2018 | 378 | 0.13 | Why? |
| Oligopeptides | 1 | 2017 | 576 | 0.13 | Why? |
| Serine Proteinase Inhibitors | 1 | 2017 | 341 | 0.12 | Why? |
| Gene Expression Regulation, Viral | 1 | 2018 | 925 | 0.12 | Why? |
| RNA Helicases | 1 | 2015 | 413 | 0.11 | Why? |
| Autophagy | 1 | 2018 | 960 | 0.11 | Why? |
| Liposomes | 2 | 2021 | 334 | 0.10 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2018 | 2134 | 0.10 | Why? |
| Mice | 5 | 2021 | 21357 | 0.10 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.10 | Why? |
| Sweden | 3 | 2021 | 1969 | 0.10 | Why? |
| Furin | 1 | 2017 | 1054 | 0.10 | Why? |
| Indoles | 1 | 2018 | 1243 | 0.10 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.10 | Why? |
| Amino Acid Sequence | 1 | 2020 | 6049 | 0.09 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.09 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.09 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.08 | Why? |
| Melanoma | 1 | 2018 | 1229 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Mice, Inbred C57BL | 3 | 2021 | 5542 | 0.08 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.08 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.07 | Why? |
| Chikungunya virus | 2 | 2018 | 339 | 0.07 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.06 | Why? |
| Host-Pathogen Interactions | 3 | 2018 | 11041 | 0.06 | Why? |
| Mutation | 3 | 2018 | 12376 | 0.06 | Why? |
| Protein Structure, Quaternary | 1 | 2004 | 455 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Click Chemistry | 1 | 2020 | 66 | 0.05 | Why? |
| Virus Replication | 2 | 2019 | 14331 | 0.05 | Why? |
| Aluminum Hydroxide | 1 | 2021 | 133 | 0.05 | Why? |
| Hydrogen-Ion Concentration | 1 | 2004 | 993 | 0.05 | Why? |
| Membrane Fusion | 1 | 2004 | 713 | 0.05 | Why? |
| Squalene | 1 | 2021 | 196 | 0.05 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Immunization | 2 | 2021 | 2019 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| CapZ Actin Capping Protein | 1 | 2018 | 1 | 0.05 | Why? |
| Sirtuins | 1 | 2018 | 27 | 0.05 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.04 | Why? |
| Diphtheria Toxin | 1 | 2017 | 9 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Dried Blood Spot Testing | 1 | 2021 | 383 | 0.04 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Poly I-C | 1 | 2017 | 176 | 0.04 | Why? |
| Virulence | 1 | 2004 | 2172 | 0.04 | Why? |
| Humans | 13 | 2021 | 930598 | 0.04 | Why? |
| Codon | 1 | 2017 | 287 | 0.04 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.04 | Why? |
| Interleukin-17 | 1 | 2021 | 602 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2018 | 310 | 0.04 | Why? |
| Disease Resistance | 1 | 2017 | 236 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Drug Synergism | 1 | 2018 | 833 | 0.04 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.03 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.03 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.03 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.02 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Female | 6 | 2021 | 380317 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.00 | Why? |
McInerney's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(119)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_